苏珊 广州市胸科医院 肿瘤内科 主任医师

教育经历：

2015/09-2018/12，南方医科大学，博士研究生， 导师：吴一龙

2004/09-2007/07，南方医科大学，肿瘤学，硕士，导师：张健

1999/09-2004/07，第一军医院大学，临床医学院，本科

工作经历：

2017.11至今 广州市胸科医院，肿瘤科，副主任、主任医师

2012-04至2017-12 广州市胸科医院，肿瘤科，主治医师

2008-08至2012-03 广州市胸科医院，肿瘤科，住院医师

学术任职：

广东省医学会肺部肿瘤学分会 委员

广东省女医师协会肺癌专委会 常委

广东省精准医学应用学会慢性呼吸道分会 常委

广东省保健协会免疫细胞与干细胞治疗专委会 常委

广东省医学教育协会肿瘤诊疗技术转化专委会 常委

科研立项：

在研项目：5项；在研经费：106万元

论文发表：

近5年在以第一作者在 BMC Medicine, J Thorac Oncol, J Hematol Oncol等杂志发表SCI论文多篇，单篇最高影响因子12.46，累积影响因子超过50分。

(1) Su, Shan#; Dong, Zhong Yi#; Xie, Zhi#; Yan, Li Xu; Li, Yu Fa; Su, Jian; Liu, Si Yang; Yin, Kai; Chen, Rui Lian; Huang, Shu Mei; Chen, Zhi Hong; Yang, Jin Ji; Tu, Hai Yan; Zhou, Qing; Zhong, Wen Zhao; Zhang, Xu Chao; Wu, Yi Long ;* Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation , Journal of Thoracic Oncology, 2018, 13(11): 1668-1675.

(2) Su, Shan#; Wu, Yi Long ; * Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review , Journal of Hematology & Oncology, 2017, 10(1): 147-157.

(3) Su S.#; Zou J.-J.#; Zeng Y.-Y.; Cen W.-C.; Zhou W.; Liu Y.; Su D.-H.; Zhang X.-L.; Huang H.-Y.; Lei A.; Huang Z.-H.; Jin Y.; Li L.; Su N.; Xie Y.-L.; Zhao Z.-G. ; Liu J.-X. ; * * Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing , Biomed Research International, 2019, 2019: 1-8.

（4）Zou, Jianjun#; Su, Shan#; Chen, Zhuohong; Liang, Feng; Zeng, Yunyun; Cen, Wenchang; Zhang, Xianlan; Xia, Yu ; Huang, Donglan ; * * Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxei in lung cancer therapy , Artificial Cells Nanomedicine and Biotechnology, 2019, 47(1): 3456-3464

（5）Zheng, Rui#; Su, Shan#; Zhou, Huifang; Yan, Huaifeng; Ye, Junhua; Zhao, Zhengang ; You, Lijun; Fu, Xiong* ；Antioxidant/antihyperglycemic activity of phenolics from sugarcane (Saccharum officinarum L.) bagasse and identification by UHPLC-HR-TOFMS , Industrial Crops and Products, 2017, 101: 104-114.

（6）Zheng, Rui#; Su, Shan#, Jianbin Li , Zhengang Zhao^⁎, , Juan Wei , Xiong Fu , Rui Hai Liu; Recovery of phenolics from the ethanolic extract of sugarcane (Saccharum officinarum L.) baggase and evaluation of the antioxidant and antiproliferative activities. Industrial Crops and Products, 2017, 107：360-369.

（7）Ye Mei-feng^#, Su Shan^#, Huang Zhi-hao et al. Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis . Ann Transl Med, 2020;8(18):1143.

（8）Shan Su^#, Anqi Lin^#, Peng Luo^# et al.Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer.Ann Transl Med,2021;9(18):1475.

（9）Shan Su† , Mei-Feng Ye† , Xiao-Ting Cai† et al.Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage.BMC Medicine (2021) 19:322.